Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials

Published:2017-12-06 Issue:2 Volume:14 Page:314-321
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Xu Xiaoqun¹²,Zhu Houyong³,Lv Huoyang¹

Affiliation:

1. Department of Clinical Laboratory, Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital, The Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China

2. Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

3. Department of Cardiology, Hangzhou Hospital of Traditional Chinese Medicine; Hangzhou Dingqiao Hospital, Hangzhou, Zhejiang, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1395540

Reference31 articles.

1. Prophylactic use of intraoperative vancomycin powder and postoperative infection: an analysis of microbiological patterns in 1200 consecutive surgical cases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Staphylococcus aureus vaccine strategy: Promise and challenges;Microbiological Research;2023-06

2. Impact of industry sponsorship on the quality of systematic reviews of vaccines: a cross-sectional analysis of studies published from 2016 to 2019;Systematic Reviews;2022-08-22

3. Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines;Gene Reports;2020-09

4. A synergistic association between adhesion-related genes and multidrug resistance patterns of Staphylococcus aureus isolates from different patients and healthy individuals;Journal of Global Antimicrobial Resistance;2020-09

Recent advances in Staphylococcus aureus infection: focus on vaccine development

;Infection and Drug Resistance;2019-05